The Traderszone Network

Published in TZ Latest News 27 January, 2017 by The TZ Newswire Staff

Why Chemours’ 300% Gain in 2016 Isn’t as Impressive as it Sounds

Three. Hundred. Percent.

That’s how much the stock of chemical company Chemours (NYSE: CC) grew last year. It’s all the more impressive considering that Chemours, a DuPont (NYSE: DD) spinoff, is in the sleepy chemical and materials science industry, and it isn’t even a major player in the industry at that.

read more